_version_ 1783306185600925696
author Torok, Rachel D.
Li, Jennifer S.
Kannankeril, Prince J.
Atz, Andrew M.
Bishai, Raafat
Bolotin, Ellen
Breitenstein, Stefanie
Chen, Cathy
Diacovo, Thomas
Feltes, Timothy
Furlong, Patricia
Hanna, Michael
Graham, Eric M.
Hsu, Daphne
Ivy, D. Dunbar
Murphy, Dianne
Kammerman, Lisa A.
Kearns, Gregory
Lawrence, John
Lebeaut, Brigitte
Li, Danshi
Male, Christoph
McCrindle, Brian
Mugnier, Pierre
Newburger, Jane W.
Pearson, Gail D.
Peiris, Vasum
Percival, Lisa
Pina, Miriam
Portman, Ronald
Shaddy, Robert
Stockbridge, Norman L.
Temple, Robert
Hill, Kevin D.
author_facet Torok, Rachel D.
Li, Jennifer S.
Kannankeril, Prince J.
Atz, Andrew M.
Bishai, Raafat
Bolotin, Ellen
Breitenstein, Stefanie
Chen, Cathy
Diacovo, Thomas
Feltes, Timothy
Furlong, Patricia
Hanna, Michael
Graham, Eric M.
Hsu, Daphne
Ivy, D. Dunbar
Murphy, Dianne
Kammerman, Lisa A.
Kearns, Gregory
Lawrence, John
Lebeaut, Brigitte
Li, Danshi
Male, Christoph
McCrindle, Brian
Mugnier, Pierre
Newburger, Jane W.
Pearson, Gail D.
Peiris, Vasum
Percival, Lisa
Pina, Miriam
Portman, Ronald
Shaddy, Robert
Stockbridge, Norman L.
Temple, Robert
Hill, Kevin D.
author_sort Torok, Rachel D.
collection PubMed
description
format Online
Article
Text
id pubmed-5850184
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58501842018-03-21 Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank Torok, Rachel D. Li, Jennifer S. Kannankeril, Prince J. Atz, Andrew M. Bishai, Raafat Bolotin, Ellen Breitenstein, Stefanie Chen, Cathy Diacovo, Thomas Feltes, Timothy Furlong, Patricia Hanna, Michael Graham, Eric M. Hsu, Daphne Ivy, D. Dunbar Murphy, Dianne Kammerman, Lisa A. Kearns, Gregory Lawrence, John Lebeaut, Brigitte Li, Danshi Male, Christoph McCrindle, Brian Mugnier, Pierre Newburger, Jane W. Pearson, Gail D. Peiris, Vasum Percival, Lisa Pina, Miriam Portman, Ronald Shaddy, Robert Stockbridge, Norman L. Temple, Robert Hill, Kevin D. J Am Heart Assoc Special Report John Wiley and Sons Inc. 2018-02-10 /pmc/articles/PMC5850184/ /pubmed/29440007 http://dx.doi.org/10.1161/JAHA.117.007283 Text en © 2018 The Authors, Janssen, and Bristol Myers Squibb. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Special Report
Torok, Rachel D.
Li, Jennifer S.
Kannankeril, Prince J.
Atz, Andrew M.
Bishai, Raafat
Bolotin, Ellen
Breitenstein, Stefanie
Chen, Cathy
Diacovo, Thomas
Feltes, Timothy
Furlong, Patricia
Hanna, Michael
Graham, Eric M.
Hsu, Daphne
Ivy, D. Dunbar
Murphy, Dianne
Kammerman, Lisa A.
Kearns, Gregory
Lawrence, John
Lebeaut, Brigitte
Li, Danshi
Male, Christoph
McCrindle, Brian
Mugnier, Pierre
Newburger, Jane W.
Pearson, Gail D.
Peiris, Vasum
Percival, Lisa
Pina, Miriam
Portman, Ronald
Shaddy, Robert
Stockbridge, Norman L.
Temple, Robert
Hill, Kevin D.
Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title_full Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title_fullStr Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title_full_unstemmed Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title_short Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank
title_sort recommendations to enhance pediatric cardiovascular drug development: report of a multi‐stakeholder think tank
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850184/
https://www.ncbi.nlm.nih.gov/pubmed/29440007
http://dx.doi.org/10.1161/JAHA.117.007283
work_keys_str_mv AT torokracheld recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT lijennifers recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT kannankerilprincej recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT atzandrewm recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT bishairaafat recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT bolotinellen recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT breitensteinstefanie recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT chencathy recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT diacovothomas recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT feltestimothy recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT furlongpatricia recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT hannamichael recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT grahamericm recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT hsudaphne recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT ivyddunbar recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT murphydianne recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT kammermanlisaa recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT kearnsgregory recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT lawrencejohn recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT lebeautbrigitte recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT lidanshi recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT malechristoph recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT mccrindlebrian recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT mugnierpierre recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT newburgerjanew recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT pearsongaild recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT peirisvasum recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT percivallisa recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT pinamiriam recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT portmanronald recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT shaddyrobert recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT stockbridgenormanl recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT templerobert recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank
AT hillkevind recommendationstoenhancepediatriccardiovasculardrugdevelopmentreportofamultistakeholderthinktank